JESSICA SMITH CHASSE: Open Payments
NPI 1679094601 · MYRTLE BEACH, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$597 in 24 payments from 9 companies in 2025. Trend: 2023 $382 · 2024 $453 · 2025 $597
Food & beverage: $497Education: $100
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 3 | $147 |
| Amgen Inc. | 4 | $141 |
| ABBVIE INC. | 9 | $140 |
| Novo Nordisk Inc | 2 | $51 |
| Lilly USA, LLC | 2 | $39 |
| Abbott Laboratories | 1 | $23 |
| Corcept Therapeutics | 1 | $22 |
| AstraZeneca Pharmaceuticals LP | 1 | $19 |
| Dexcom, Inc. | 1 | $15 |
Products named: REPATHA, UBRELVY, Veozah, QULIPTA, Ozempic, JARDIANCE, FREESTYLE LIBRE 3, Korlym.
Industry payments across SC — which companies pay providers there.
